KI-DEUK WOHLFERT: Open Payments
NPI 1679610885 · AUBURN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 21 payments from 10 companies in 2025. Trend: 2023 $533 · 2024 $270 · 2025 $548
Food & beverage: $514Education: $34
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $219 |
| Aimmune Therapeutics, Inc. | 3 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Lilly USA, LLC | 1 | $33 |
| Corcept Therapeutics | 1 | $33 |
| Fidia Pharma USA Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: LINZESS, ZENPEP, CREON, Kerendia, JARDIANCE, Korlym, HYALGAN, SHINGRIX.
Industry payments across WA — which companies pay providers there.
